Biotech Values

[Whalatane]

Dew re AMRN

At March 31, 2022, the Company had Total assets of
$973.7 million, of which $389.3
million consisted of cash and liquid short-term and long-term
investments.

More specifically, the Company had Current assets
of $772.6 million, including Cash and cash equivalents of
$219.2 million, Short-term investments of
$143.4 million, Accounts receivable, net, of $110.2
million and Inventory of $267.8 million.

In addition, as of March 31, 2022, the Company had
Long-term investments of $26.7
million and Long-term inventory of $141.1 million.

As of March 31, 2022, the Company had no debt outstanding.

If the total assets are $973 m ( or current assets of $772.6 m ) and market cap is currently $504 m ...how do you come up with your EV figure ?
Thx ...I've been adding based on EU / UK market potential .

SWAV came in with an excellent report and raised guidance .
Stock ( like most ) has been trashed lately .

Kiwi